Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Nichols

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
NIDA Research Monograph|January 1, 1989
Structure-activity relationships of MDMA-like substancesD E Nichols, R Oberlender
Psychopharmacology|January 1, 1988
Drug discrimination studies with MDMA and amphetamineR Oberlender, D E Nichols
Annals of the New York Academy of Sciences|January 1, 1990
Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs?D E Nichols, R Oberlender
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|February 21, 1998
Oat cell carcinoma metastasis to the footL A Delgadillo, D E Nichols
Journal of Medicinal Chemistry|May 1, 1982
Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogueJ N Jacob, D E Nichols
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1995
The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficitsJ E Sprague, D E Nichols
European Journal of Pharmacology|June 2, 1994
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindanD Marona-Lewicka, D E Nichols
Trends in Pharmacological Sciences|August 15, 1998
Dopamine D1 receptor agonists as antiparkinson drugsR B Mailman, D E Nichols
European Journal of Pharmacology|July 23, 1991
Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analoguesJ F Nash, D E Nichols
Journal of Medicinal Chemistry|April 1, 1971
Potential psychotomimetics. BromomethoxyamphetaminesC F Barfknecht, D E Nichols
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
NIDA Research Monograph|January 1, 1989
Structure-activity relationships of MDMA-like substancesD E Nichols, R Oberlender
Psychopharmacology|January 1, 1988
Drug discrimination studies with MDMA and amphetamineR Oberlender, D E Nichols
Annals of the New York Academy of Sciences|January 1, 1990
Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs?D E Nichols, R Oberlender
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|February 21, 1998
Oat cell carcinoma metastasis to the footL A Delgadillo, D E Nichols
Journal of Medicinal Chemistry|May 1, 1982
Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogueJ N Jacob, D E Nichols
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1995
The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficitsJ E Sprague, D E Nichols
European Journal of Pharmacology|June 2, 1994
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindanD Marona-Lewicka, D E Nichols
Trends in Pharmacological Sciences|August 15, 1998
Dopamine D1 receptor agonists as antiparkinson drugsR B Mailman, D E Nichols
European Journal of Pharmacology|July 23, 1991
Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analoguesJ F Nash, D E Nichols
Journal of Medicinal Chemistry|April 1, 1971
Potential psychotomimetics. BromomethoxyamphetaminesC F Barfknecht, D E Nichols
Pageof 19